Monthly Archives: October 2013

BIO Moderates Discussion on Important Industrial & Environmental Issues

Gas-Can-Spilling-Corn-115x76

On Wednesday, October 30th, OurEnergyPolicy.org began hosting a discussion on the blend wall and the Renewable Fuel Standard, moderated by BIO’s Dr. Matt Carr, Managing Director, Policy, and Industrial & Environmental. BIO has been working with this independent group to increase robust participation in the discussion and encourages not only BIO’s member companies to participate but additional parties, expert on the topic, to submit comments as well. This is an opportunity for stakeholders in the RFS to Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Renewable Chemicals and Biobased Consumer Products Featured at BIO’s 2013 Pacific Rim Summit

Pac_Rim115x75

The Biotechnology Industry Organization’s (BIO)’s 2013 Pacific Rim Summit on Biotechnology and Bioenergy will be showcasing several inimitable presentations on the use of renewable chemicals to replace petroleum chemicals to meet rapidly growing consumer demand for environmentally healthy products.  This year’s summit will be co-organized by BIOCOM and held in San Diego, California from December 8-11, 2013 at the Westin Gaslamp Quarter. In a recent press release, BIO announced that the Pacific Rim Summit will offer a Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Innovation Is… with David Pyott of Allergan, Inc

David Pyott

The term innovation is thrown around more often than Peyton Manning’s name during Fantasy Football season. But if any industry can truly capture the essence of innovation, it is the biotech industry. Innovation is inherent in what we do – from curing or treating illnesses that were once considered a death sentence to feeding a growing population to helping to reduce our dependence on foreign oil through the production of biofuels. But what is innovation, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Washington State Initiative 522 Losing Momentum and Losing Standing with Voters

No-on-522-2 copy

“Its air leaking, I-522′s balloon is going flat” With November 5 rapidly approaching the voters of Washington State, residents are being faced with a contentious piece of legislation on this year’s ballot. Washington State I-522 will require the labeling of genetically engineered (GE) foods and food with GE ingredients beginning in 2015. Supported by robust scientific analysis, GE crops have been found to be as safe or safer than conventional as well as organic crops to Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , ,

Neglected Diseases: What if IP was the Cure?

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

The Lancet Global Health Journal recently published an article “The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment” discussing the current research and development ongoing in this area.  They found 1,500 clinical trials were registered for neglected diseases which represents only 1% of all registered clinical trial activity.  Of the 123 new products in development for neglected disease, more than half were vaccines or biological products.  However, the article points out that Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , ,